Randomized Adjuvant Chemotherapy Trial in High-Risk, Lymph Node-Negative Breast Cancer Patients Identified by Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor Type 1

Breast Cancer Patients ◽

Node Negative ◽

Node Negative Breast Cancer ◽

Inhibitor Type ◽

Activator Inhibitor Type

Plasminogen Activator Inhibitor Type 1 is the Most Significant of the Usual Tissue Prognostic Factors in Node-Negative Breast Ductal Adenocarcinoma Independent of Urokinase-Type Plasminogen Activator

Clinical Breast Cancer ◽

10.3816/cbc.2008.n.018 ◽

2008 ◽

Vol 8 (2) ◽

pp. 168-177 ◽

Cited By ~ 15

Author(s):

Françoise Descotes ◽

Benjamin Riche ◽

Simone Saez ◽

Guy De Laroche ◽

Jean Datchary ◽

...

Keyword(s):

Plasminogen Activator ◽

Ductal Adenocarcinoma ◽

Node Negative ◽

Inhibitor Type ◽

Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: Comparison to antigen quantification by ELISA

International Journal of Molecular Medicine ◽

10.3892/ijmm.21.2.251 ◽

2008 ◽

Author(s):

Julia Biermann ◽

Leon Holzscheiter ◽

Matthias Kotzsch ◽

Thomas Luther ◽

Marion Kiechle-Bahat ◽

...

Keyword(s):

Plasminogen Activator ◽

Breast Cancer Patients ◽

Inhibitor Type ◽

Elevated levels of urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 in malignant human brain tumors

Fibrinolysis and Proteolysis ◽

10.1016/0268-9499(94)90453-7 ◽

1994 ◽

Vol 8 ◽

pp. 61 ◽

Cited By ~ 1

Author(s):

B. Landau ◽

S. Brern ◽

E. Verrusio ◽

H. Kwaan

Keyword(s):

Brain Tumors ◽

Human Brain ◽

Plasminogen Activator ◽

Inhibitor Type ◽

92 Single chain urokinase-type plasminogen activator bound to its receptor is relatively resistant to plasminogen activator inhibitor type 1

Fibrinolysis and Proteolysis ◽

10.1016/s0268-9499(96)80179-2 ◽

1996 ◽

Vol 10 ◽

pp. 30

Keyword(s):

Plasminogen Activator ◽

Single Chain ◽

Plasminogen Activator Inhibitor Type ◽

Inhibitor Type ◽

Urokinase-type Plasminogen Activator and Plasminogen Activator Inhibitor Type-1 mRNA Assessment in Breast Cancer by Means of NASBA

American Journal of Clinical Pathology ◽

10.1309/k4jaf2nmd5eju67y ◽

2007 ◽

Vol 128 (3) ◽

pp. 404-413 ◽

Cited By ~ 6

Author(s):

Pierre-Jean Lamy ◽

Thibault Verjat ◽

Anne-Claire Servanton ◽

Malik Paye ◽

Philippe Leissner ◽

...

Keyword(s):

Breast Cancer ◽

Plasminogen Activator ◽

Plasminogen Activator Inhibitor Type ◽

Inhibitor Type ◽

Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer

BMC Cancer ◽

10.1186/1471-2407-8-194 ◽

2008 ◽

Vol 8 (1) ◽

Cited By ~ 58

Author(s):

László Herszényi ◽

Fabio Farinati ◽

Romilda Cardin ◽

Gábor István ◽

László D Molnár ◽

...

Keyword(s):

Plasminogen Activator ◽

Cathepsin B ◽

Cathepsin L ◽

Inhibitor Type ◽

Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancer

Gynecologic Oncology ◽

10.1016/j.ygyno.2007.11.025 ◽

2008 ◽

Vol 108 (3) ◽

pp. 569-576 ◽

Cited By ~ 28

Author(s):

E. Steiner ◽

K. Pollow ◽

D. Hasenclever ◽

W. Schormann ◽

M. Hermes ◽

...

Keyword(s):

Plasminogen Activator ◽

Inhibitor Type ◽

Activator Inhibitor ◽

Pai 1

479 Expression of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 in human brain tumors primary cultures

Fibrinolysis and Proteolysis ◽

10.1016/s0268-9499(96)80565-0 ◽

1996 ◽

Vol 10 ◽

pp. 138

Keyword(s):

Brain Tumors ◽

Plasminogen Activator ◽

Primary Cultures ◽

Inhibitor Type ◽

Expression and prognostic value of plasminogen activator inhibitor type 1 in node-negative breast cancer

The Chinese-German Journal of Clinical Oncology ◽

10.1007/s10330-008-0030-2 ◽

2008 ◽

Vol 7 (6) ◽

pp. 339-343 ◽

Cited By ~ 1

Author(s):

Bin Wang ◽

Ning Wang ◽

Chunyan Xue ◽

Bin Jiang ◽

Yajie Wang

Keyword(s):

Breast Cancer ◽

Plasminogen Activator ◽

Prognostic Value ◽

Node Negative ◽

Node Negative Breast Cancer ◽

Inhibitor Type ◽

Temporal expression of urokinase type plasminogen activator, tissue type plasminogen activator, plasminogen activator inhibitor type 1 in rhesus monkey corpus luteum during the luteal maintenance and regression

Molecular and Cellular Endocrinology ◽

10.1016/s0303-7207(97)00152-4 ◽

1997 ◽

Vol 133 (2) ◽

pp. 109-116 ◽

Cited By ~ 15

Author(s):

K. Liu ◽

Y.-X. Liu ◽

Z.-Y. Hu ◽

R.-Y. Zou ◽

Y.-J. Chen ◽

...

Keyword(s):

Plasminogen Activator ◽

Tissue Type ◽

Temporal Expression ◽

Inhibitor Type ◽